[Evaluation of bone mineral density using digital image processing in children receiving anticonvulsants]

Area of Science:

• Pediatric endocrinology and neurology
• Bone metabolism and skeletal development
• Pharmacological effects on growth

Context:

• Childhood bone mineral density (BMD) accrual is biphasic and closely linked to bone age during adolescence.
• Digital image processing (DIP) offers a method for simultaneous BMD and bone age assessment from X-rays.
• Epilepsy patients on anticonvulsants require careful monitoring for potential effects on bone health.

Purpose:

• To investigate the impact of various anticonvulsants (valproate sodium, carbamazepine, phenobarbital) on chronological and bone age in children with epilepsy.
• To evaluate the relationship between anticonvulsant administration duration and bone mineral density (BMD) Z-scores.
• To determine if anticonvulsant therapy affects bone maturation and bone age determination.

Summary:

• A study of 98 epilepsy patients (ages 3-15) using DIP found that while multiple anticonvulsants correlated with decreased BMD Z-scores based on chronological age, no significant differences in BMD were observed based on bone age.
• Long-term valproate sodium (VPA) administration was associated with a potential delay in bone age (approximately 1 year), suggesting an impact on bone maturation.
• However, children on long-term multiple anticonvulsant therapy did not show delayed bone age, indicating these drugs may not universally affect bone maturity.

Impact:

• Highlights the importance of considering bone age, not just chronological age, when interpreting BMD in children with epilepsy undergoing anticonvulsant treatment.
• Suggests that while some anticonvulsants might influence bone maturation, the overall effect on bone maturity in polytherapy requires further investigation.
• Emphasizes the need for tailored assessment of bone health in pediatric epilepsy patients to account for drug-specific and combination therapy effects.